Holland Advisory Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$617K Buy
2,430
+1
+0% +$233 0.68% 19
2026
Q1
$594K Buy
2,429
+80
+3% +$18.6K 0.8% 16
2025
Q4
$486K Buy
2,349
+1
+0% +$198 0.66% 19
2025
Q3
$435K Buy
2,348
+1
+0% +$171 0.6% 21
2025
Q2
$358K Buy
2,347
+1
+0% +$154 0.52% 27
2025
Q1
$389K Buy
2,346
+2
+0.1% +$313 0.59% 24
2024
Q4
$339K Buy
2,344
+1
+0% +$155 0.44% 27
2024
Q3
$380K Sell
2,343
-119
-5% -$19K 0.5% 27
2024
Q2
$360K Sell
2,462
-6
-0.2% -$892 0.44% 26
2024
Q1
$390K Buy
2,468
+11
+0.4% +$1.75K 0.43% 24
2023
Q4
$385K Sell
2,457
-694
-22% -$106K 0.44% 23
2023
Q3
$491K Buy
3,151
+672
+27% +$111K 0.62% 16
2023
Q2
$410K Buy
2,479
+2
+0.1% +$323 0.52% 15
2023
Q1
$384K Buy
2,477
+3
+0.1% +$484 0.45% 18
2022
Q4
$437K Buy
2,474
+2
+0.1% +$345 0.52% 16
2022
Q3
$404K Sell
2,472
-336
-12% -$56.9K 0.5% 18
2022
Q2
$499K Sell
2,808
-11
-0.4% -$1.96K 0.6% 19
2022
Q1
$500K Buy
2,819
+2
+0.1% +$340 0.58% 22
2021
Q4
$482K Buy
+2,817
New +$461K 0.56% 23

Other funds holding JNJ

Holland Advisory Services's JNJ Position: Q2 2026 in Review

Holland Advisory Services increased its Johnson & Johnson (JNJ) stake by 0.04% in Q2 2026, buying an estimated $233 and bringing the position to 2,430 shares worth $617K. The position accounts for 0.68% of the portfolio, ranked #19.

Holland Advisory Services first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,195 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Holland Advisory Services held 2,430 shares of Johnson & Johnson worth $617K as of Q2 2026.
  • Holland Advisory Services bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.68% of Holland Advisory Services's portfolio in Q2 2026, its #19 holding.
  • Holland Advisory Services first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,195 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Holland Advisory Services's 13F filing for Q2 2026, filed 13 Jul 2026.